J. Roques

发表

Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.

David B. Darr, K. Williams, G. Devi, 2017, Cancer letters.

Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy

David B. Darr, I. Wilson, J. Roach, 2020, Proceedings of the National Academy of Sciences.

Review of Galactic Center Observations with Granat

N. Khavenson, R. Sunyaev, E. Churazov, 1994 .

Autoreactive Preplasma Cells Break Tolerance in the Absence of Regulation by Dendritic Cells and Macrophages

James W. Thomas, S. Gauld, B. Vilen, 2012, The Journal of Immunology.

Dendritic Cells and Macrophages Tolerance in the Absence of Regulation by Autoreactive Preplasma Cells Break

James W. Thomas, S. Gauld, B. Vilen, 2012 .

Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3β and Activates WNT Signaling

David B. Darr, D. Goldfarb, G. Johnson, 2017, Molecular Cancer Research.

New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging.

Michael L. Gatza, Steven P. Angus, David B. Darr, 2018, Cancer research.

Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.

David B. Darr, K. Williams, C. Laudeman, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

TAK1 regulates the tumor microenvironment through inflammatory, angiogenetic and apoptotic signaling cascades

Philip F. Hughes, T. Haystead, J. Roques, 2020, Oncotarget.

A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo.

Philip F. Hughes, David B. Darr, T. Haystead, 2017, ACS chemical biology.

Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion

Philip F. Hughes, D. Loiselle, T. Haystead, 2018, Scientific Reports.

Receptor Cross-Talk Spatially Restricts p-ERK during TLR4 Stimulation of Autoreactive B Cells

Andrew J Monteith, B. Vilen, S. Clarke, 2012, The Journal of Immunology.

Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion

Philip F. Hughes, D. Loiselle, T. Haystead, 2018, Scientific Reports.

Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model

Sha X. Chang, David B. Darr, B. Midkiff, 2021, Therapeutic advances in medical oncology.